Immunity to toxoplasmosis in hamsters

Area of Science:

• Immunology
• Parasitology
• Vaccinology

Background:

• Toxoplasma gondii poses a significant public health threat.
• Understanding protective immunity is crucial for vaccine development.
• Hamsters serve as a relevant model for studying toxoplasmosis immunity.

Purpose of the Study:

• To evaluate the efficacy of different Toxoplasma vaccine candidates in hamsters.
• To investigate the role of premunition and delayed-type hypersensitivity in protective immunity.
• To compare the quality of immune responses induced by live and killed vaccines.

Main Methods:

• Hamsters were vaccinated with live (RH, T-45, ts-4) or killed Toxoplasma strains.
• Vaccinated hamsters were challenged with virulent Toxoplasma strains (RH and T-1).
• Immunity, antibody titers, delayed-type hypersensitivity, and clinical signs were monitored.

Main Results:

• Live RH, T-45, and ts-4 strains provided the best protection against the highly pathogenic RH strain.
• Killed-Toxoplasma vaccine protected against the T-1 strain but not the RH strain.
• Immunity induced by ts-4 and killed vaccine was independent of premunition.
• Delayed-type hypersensitivity appeared before protective immunity but was not a definitive indicator.

Conclusions:

• Live Toxoplasma vaccines, particularly the RH, T-45, and ts-4 strains, are more effective than killed vaccines against virulent challenge.
• The development of protective immunity is not solely dependent on premunition.
• Delayed-type hypersensitivity is an early marker but does not predict the presence or development of protective immunity.